Improving lung cancer survival; time to move on

by Heuvers Marlies E, Hegmans Joost P, Stricker Bruno H, Aerts Joachim G
Published 2012-12-01

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment

by Heuvers Marlies E, Aerts Joachim G, Cornelissen Robin, Groen Harry, Hoogsteden Henk C, Hegmans Joost P
Published 2012-12-01

Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma

by Tan Youke KY, Liem Hauw, Antonisse Imogeen E, Senan Suresh, Cornelissen Robin, Rudolphus Arjan, Aerts Joachim GJV
Published 2007-01-01

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

by Veltman Joris D, Lambers Margaretha EH, van Nimwegen Menno, Hendriks Rudi W, Hoogsteden Henk C, Aerts Joachim GJV, Hegmans Joost PJJ
Published 2010-08-01

Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): Study protocol for a randomised controlled trial

by Uzun Sevim, Djamin Remco S, Kluytmans JanAJW, Van’t Veer Nils E, Ermens Anton A M, Pelle Aline J, Mulder Paul, van der Eerden Menno M, Aerts JoachimGJV
Published 2012-06-01

Genome-wide DNA methylation profiling of non-small cell lung carcinomas

by Carvalho Rejane, Haberle Vanja, Hou Jun, van Gent Teus, Thongjuea Supat, van IJcken Wilfred, Kockx Christel, Brouwer Rutger, Rijkers Erikjan, Sieuwerts Anieta, Foekens John, van Vroonhoven Mirjam, Aerts Joachim, Grosveld Frank, Lenhard Boris, Philipsen Sjaak
Published 2012-06-01